Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Unknown 2 Recruiting 2 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Carcinoma, Hepatocellular 8 Stomach Neoplasms 6 Multiple Myeloma 6 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Neoplasms 4 Endometrial Neoplasms 4 Small Cell Lung Carcinoma 3 Recurrence 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Febrile Neutropenia 3 Carcinoma, Non-Small-Cell Lung 3 Waldenstrom Macroglobulinemia 2 Venous Thromboembolism 2 Skin Neoplasms 2 Pancreatic Neoplasms 2 Pancreatic Cancer Non-resectable 2 Obesity 2 Neoplasm Metastasis 2 Lymphoma, B-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hepatitis B 2 Hematologic Neoplasms 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Anemia 2 Acute Kidney Injury 2

Interventions

Rosuvastatin Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Cardiotoxicity × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡